Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.21
CMN's Cash to Debt is ranked lower than
81% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.56 vs. CMN: 0.21 )
Ranked among companies with meaningful Cash to Debt only.
CMN' s Cash to Debt Range Over the Past 10 Years
Min: 0.05  Med: 0.35 Max: No Debt
Current: 0.21
Equity to Asset 0.62
CMN's Equity to Asset is ranked lower than
51% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. CMN: 0.62 )
Ranked among companies with meaningful Equity to Asset only.
CMN' s Equity to Asset Range Over the Past 10 Years
Min: 0.46  Med: 0.62 Max: 0.81
Current: 0.62
0.46
0.81
Interest Coverage 32.28
CMN's Interest Coverage is ranked lower than
54% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 51.90 vs. CMN: 32.28 )
Ranked among companies with meaningful Interest Coverage only.
CMN' s Interest Coverage Range Over the Past 10 Years
Min: 3.63  Med: 17.90 Max: 33.21
Current: 32.28
3.63
33.21
F-Score: 5
Z-Score: 7.82
M-Score: -2.47
WACC vs ROIC
10.96%
11.56%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 14.69
CMN's Operating margin (%) is ranked higher than
76% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.71 vs. CMN: 14.69 )
Ranked among companies with meaningful Operating margin (%) only.
CMN' s Operating margin (%) Range Over the Past 10 Years
Min: 7.2  Med: 11.24 Max: 14.87
Current: 14.69
7.2
14.87
Net-margin (%) 8.76
CMN's Net-margin (%) is ranked higher than
67% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.63 vs. CMN: 8.76 )
Ranked among companies with meaningful Net-margin (%) only.
CMN' s Net-margin (%) Range Over the Past 10 Years
Min: 3.49  Med: 7.70 Max: 12.33
Current: 8.76
3.49
12.33
ROE (%) 12.82
CMN's ROE (%) is ranked higher than
75% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.28 vs. CMN: 12.82 )
Ranked among companies with meaningful ROE (%) only.
CMN' s ROE (%) Range Over the Past 10 Years
Min: 5.37  Med: 11.17 Max: 19
Current: 12.82
5.37
19
ROA (%) 8.59
CMN's ROA (%) is ranked higher than
75% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.45 vs. CMN: 8.59 )
Ranked among companies with meaningful ROA (%) only.
CMN' s ROA (%) Range Over the Past 10 Years
Min: 3.2  Med: 7.72 Max: 11.75
Current: 8.59
3.2
11.75
ROC (Joel Greenblatt) (%) 55.47
CMN's ROC (Joel Greenblatt) (%) is ranked higher than
88% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.36 vs. CMN: 55.47 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CMN' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 25.9  Med: 41.59 Max: 61.13
Current: 55.47
25.9
61.13
Revenue Growth (3Y)(%) 12.40
CMN's Revenue Growth (3Y)(%) is ranked higher than
80% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. CMN: 12.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CMN' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0.8  Med: 12.40 Max: 29.4
Current: 12.4
0.8
29.4
EBITDA Growth (3Y)(%) 13.80
CMN's EBITDA Growth (3Y)(%) is ranked higher than
64% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.60 vs. CMN: 13.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CMN' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 1.2  Med: 17.60 Max: 40.8
Current: 13.8
1.2
40.8
EPS Growth (3Y)(%) 13.80
CMN's EPS Growth (3Y)(%) is ranked higher than
66% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.40 vs. CMN: 13.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CMN' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -5.5  Med: 23.40 Max: 45.6
Current: 13.8
-5.5
45.6
» CMN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

CMN Guru Trades in Q1 2015

Ron Baron 700,000 sh (+15.68%)
Chuck Royce Sold Out
Ken Fisher Sold Out
Mario Gabelli 349,438 sh (-5.82%)
Joel Greenblatt 7,967 sh (-12.15%)
Jim Simons 9,300 sh (-38.41%)
» More
Q2 2015

CMN Guru Trades in Q2 2015

Ron Baron 700,000 sh (unchged)
Joel Greenblatt Sold Out
Jim Simons Sold Out
Mario Gabelli 309,338 sh (-11.48%)
» More
Q3 2015

CMN Guru Trades in Q3 2015

Ron Baron 700,000 sh (unchged)
Mario Gabelli 265,288 sh (-14.24%)
» More
Q4 2015

CMN Guru Trades in Q4 2015

Mario Gabelli 244,287 sh (-7.92%)
» More
» Details

Insider Trades

Latest Guru Trades with CMN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Cantel Medical Corp

Cantel Medical Corp. Insider Sells Shares Cantel CEO sold 22,981 shares of the company on Oct. 14
Andrew Krakauer (Insider Trades), CEO of Cantel Medical Corp. (CMN), sold 22,981 shares of the company on Oct. 14. The per share was $54.22 for a total transaction of $1,246,030. Cantel Medical Corp. delivers infection prevention and control product and services for patients, caregivers, and other healthcare providers, which improve outcomes, enhance safety and help save lives. The company has a market cap of $2.23 billion and a P/S ratio of 4.02. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 47.06
CMN's P/E(ttm) is ranked lower than
73% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.60 vs. CMN: 47.06 )
Ranked among companies with meaningful P/E(ttm) only.
CMN' s P/E(ttm) Range Over the Past 10 Years
Min: 9.23  Med: 21.51 Max: 53.32
Current: 47.06
9.23
53.32
PE(NRI) 47.06
CMN's PE(NRI) is ranked lower than
74% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.30 vs. CMN: 47.06 )
Ranked among companies with meaningful PE(NRI) only.
CMN' s PE(NRI) Range Over the Past 10 Years
Min: 11.85  Med: 22.82 Max: 53.28
Current: 47.06
11.85
53.28
P/B 5.78
CMN's P/B is ranked lower than
81% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. CMN: 5.78 )
Ranked among companies with meaningful P/B only.
CMN' s P/B Range Over the Past 10 Years
Min: 0.77  Med: 1.95 Max: 6.55
Current: 5.78
0.77
6.55
P/S 4.10
CMN's P/S is ranked lower than
69% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.46 vs. CMN: 4.10 )
Ranked among companies with meaningful P/S only.
CMN' s P/S Range Over the Past 10 Years
Min: 0.51  Med: 1.48 Max: 4.65
Current: 4.1
0.51
4.65
PFCF 48.61
CMN's PFCF is ranked lower than
75% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.00 vs. CMN: 48.61 )
Ranked among companies with meaningful PFCF only.
CMN' s PFCF Range Over the Past 10 Years
Min: 7.31  Med: 17.51 Max: 810
Current: 48.61
7.31
810
POCF 38.83
CMN's POCF is ranked lower than
84% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.50 vs. CMN: 38.83 )
Ranked among companies with meaningful POCF only.
CMN' s POCF Range Over the Past 10 Years
Min: 5.66  Med: 14.68 Max: 50.63
Current: 38.83
5.66
50.63
EV-to-EBIT 30.34
CMN's EV-to-EBIT is ranked lower than
66% of the 116 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.55 vs. CMN: 30.34 )
Ranked among companies with meaningful EV-to-EBIT only.
CMN' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.3  Med: 16.10 Max: 33.9
Current: 30.34
7.3
33.9
EV-to-EBITDA 23.42
CMN's EV-to-EBITDA is ranked lower than
69% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.04 vs. CMN: 23.42 )
Ranked among companies with meaningful EV-to-EBITDA only.
CMN' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.4  Med: 11.40 Max: 26.2
Current: 23.42
5.4
26.2
PEG 2.61
CMN's PEG is ranked higher than
55% of the 64 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.97 vs. CMN: 2.61 )
Ranked among companies with meaningful PEG only.
CMN' s PEG Range Over the Past 10 Years
Min: 0.7  Med: 1.72 Max: 7.19
Current: 2.61
0.7
7.19
Shiller P/E 82.15
CMN's Shiller P/E is ranked lower than
90% of the 51 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 33.03 vs. CMN: 82.15 )
Ranked among companies with meaningful Shiller P/E only.
CMN' s Shiller P/E Range Over the Past 10 Years
Min: 11.32  Med: 28.37 Max: 92.3
Current: 82.15
11.32
92.3
Current Ratio 2.70
CMN's Current Ratio is ranked higher than
51% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.65 vs. CMN: 2.70 )
Ranked among companies with meaningful Current Ratio only.
CMN' s Current Ratio Range Over the Past 10 Years
Min: 1.45  Med: 2.76 Max: 5.07
Current: 2.7
1.45
5.07
Quick Ratio 1.65
CMN's Quick Ratio is ranked lower than
51% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. CMN: 1.65 )
Ranked among companies with meaningful Quick Ratio only.
CMN' s Quick Ratio Range Over the Past 10 Years
Min: 0.88  Med: 1.68 Max: 2.41
Current: 1.65
0.88
2.41
Days Inventory 79.47
CMN's Days Inventory is ranked higher than
79% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 131.52 vs. CMN: 79.47 )
Ranked among companies with meaningful Days Inventory only.
CMN' s Days Inventory Range Over the Past 10 Years
Min: 55.68  Med: 70.30 Max: 77.22
Current: 79.47
55.68
77.22
Days Sales Outstanding 46.35
CMN's Days Sales Outstanding is ranked higher than
77% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 64.05 vs. CMN: 46.35 )
Ranked among companies with meaningful Days Sales Outstanding only.
CMN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.46  Med: 45.20 Max: 52.34
Current: 46.35
42.46
52.34
Days Payable 16.18
CMN's Days Payable is ranked lower than
96% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 55.85 vs. CMN: 16.18 )
Ranked among companies with meaningful Days Payable only.
CMN' s Days Payable Range Over the Past 10 Years
Min: 18.96  Med: 21.77 Max: 25.88
Current: 16.18
18.96
25.88

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.19
CMN's Dividend Yield is ranked lower than
94% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.43 vs. CMN: 0.19 )
Ranked among companies with meaningful Dividend Yield only.
CMN' s Dividend Yield Range Over the Past 10 Years
Min: 0.15  Med: 0.30 Max: 0.7
Current: 0.19
0.15
0.7
Dividend Payout 0.08
CMN's Dividend Payout is ranked higher than
94% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.36 vs. CMN: 0.08 )
Ranked among companies with meaningful Dividend Payout only.
CMN' s Dividend Payout Range Over the Past 10 Years
Min: 0.13  Med: 0.17 Max: 0.22
Current: 0.08
0.13
0.22
Dividend Growth (3y) 17.30
CMN's Dividend Growth (3y) is ranked higher than
72% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.20 vs. CMN: 17.30 )
Ranked among companies with meaningful Dividend Growth (3y) only.
CMN' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 19.3
Current: 17.3
0
19.3
Forward Dividend Yield 0.20
CMN's Forward Dividend Yield is ranked lower than
95% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.43 vs. CMN: 0.20 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 0.42
CMN's Yield on cost (5-Year) is ranked lower than
86% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. CMN: 0.42 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CMN' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.35  Med: 0.70 Max: 1.62
Current: 0.42
0.35
1.62
3-Year Average Share Buyback Ratio -1.00
CMN's 3-Year Average Share Buyback Ratio is ranked higher than
65% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.00 vs. CMN: -1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CMN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -13.3  Med: -2.40 Max: -0.5
Current: -1
-13.3
-0.5

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 140.48
CMN's Price/Tangible Book is ranked lower than
98% of the 172 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.18 vs. CMN: 140.48 )
Ranked among companies with meaningful Price/Tangible Book only.
CMN' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.6  Med: 6.37 Max: 141.14
Current: 140.48
1.6
141.14
Price/Projected FCF 2.63
CMN's Price/Projected FCF is ranked lower than
74% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. CMN: 2.63 )
Ranked among companies with meaningful Price/Projected FCF only.
CMN' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.59  Med: 1.31 Max: 5.04
Current: 2.63
0.59
5.04
Price/DCF (Earnings Based) 1.68
CMN's Price/DCF (Earnings Based) is ranked higher than
53% of the 19 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.68 vs. CMN: 1.68 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 2.83
CMN's Price/Median PS Value is ranked lower than
94% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.06 vs. CMN: 2.83 )
Ranked among companies with meaningful Price/Median PS Value only.
CMN' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.28  Med: 0.83 Max: 2.84
Current: 2.83
0.28
2.84
Price/Peter Lynch Fair Value 2.41
CMN's Price/Peter Lynch Fair Value is ranked lower than
55% of the 47 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.03 vs. CMN: 2.41 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CMN' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.47  Med: 1.37 Max: 6.9
Current: 2.41
0.47
6.9
Price/Graham Number 17.30
CMN's Price/Graham Number is ranked lower than
98% of the 110 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.30 vs. CMN: 17.30 )
Ranked among companies with meaningful Price/Graham Number only.
CMN' s Price/Graham Number Range Over the Past 10 Years
Min: 1.01  Med: 2.46 Max: 17.38
Current: 17.3
1.01
17.38
Earnings Yield (Greenblatt) (%) 3.27
CMN's Earnings Yield (Greenblatt) (%) is ranked higher than
60% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. CMN: 3.27 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CMN' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 3  Med: 6.20 Max: 13.8
Current: 3.27
3
13.8
Forward Rate of Return (Yacktman) (%) 21.67
CMN's Forward Rate of Return (Yacktman) (%) is ranked higher than
86% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.84 vs. CMN: 21.67 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CMN' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 10.4  Med: 20.00 Max: 25.6
Current: 21.67
10.4
25.6

More Statistics

Revenue(Mil) $582
EPS $ 1.23
Beta1.25
Short Percentage of Float2.75%
52-Week Range $39.26 - 68.58
Shares Outstanding(Mil)41.70

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:CI2.Germany,
Cantel Medical Corp was incorporated in Delaware. The Company is a provider of infection prevention and control products in the healthcare market. Its operating segments include: Endoscopy, Water Purification and Filtration, Healthcare Disposables and Dialysis. Endoscopy segment offers medical device reprocessing systems, disinfectants, detergents and other supplies used to high-level disinfect flexible endoscopes. This segment also offers disposable infection control products intended to eliminate the challenges associated with proper cleaning and high-level disinfection of numerous reusable components used in gastrointestinal (GI) endoscopy procedures. Water Purification and Filtration segment offers water purification equipment and services, filtration and separation products, and disinfectants for the medical, pharmaceutical, biotech, beverage and commercial industrial markets. The healthcare Disposables segment offers single-use, infection prevention and control healthcare products used principally in the dental market including face masks, sterilization pouches, towels and bibs, tray covers, saliva ejectors, germicidal wipes, plastic cups and disinfectants. This segment also manufactures and provides biological and chemical indicators for sterility assurance monitoring services in the acute-care, alternate-care and dental markets. Dialysis segment offers medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. The Company sells and services its endoscope reprocessing equipment, high-level disinfectants, cleaners and consumables through its own United States field sales and service organization. Outside of the United States, it sells through independent distribution partners in Europe, Canada, Asia, Australia and Latin America as well as its own sales and service organizations in the Netherlands and Singapore. Its Competitors include Kimberly-Clark, 3M, Steris, Danaher/Sybron, Dentsply/Sultan Healthcare, Amcor. The Company's products are subject to regulation by the FDA, which regulates the testing, manufacturing, packaging, distribution and marketing of its medical devices and water purification devices in the United States.
» More Articles for CMN

Headlines

Articles On GuruFocus.com
Cantel Medical Corp. Insider Sells Shares Oct 15 2015 
Baron Small Cap Fund's Commentary on Cantel Medical Corp. Mar 19 2015 
Ron Baron's Top 5 New Holdings Feb 19 2015 
Cantel Medical Corp. (CMN) Sr. V.P., CFO and Treasurer Craig A Sheldon sells 2,607 Shares Mar 15 2011 
Cantel Medical Corp. Reports Operating Results (10-Q) Mar 11 2011 
Cantel Medical Corp. Reports Operating Results (10-Q) Dec 10 2010 
Cantel Medical Corp. Reports Operating Results (10-K) Oct 14 2010 
Cantel Medical Corp. Reports Operating Results (10-Q) Jun 09 2010 
Cantel Medical Corp. (CMN) President and CEO Andrew A Krakauer sells 11,505 Shares Apr 09 2010 
Cantel Medical Corp. (CMN) Chairman, 10% Owner Charles M Diker buys 5,000 Shares Oct 26 2009 

More From Other Websites
Cantel Medical Corp. breached its 50 day moving average in a Bearish Manner : February 8, 2016 Feb 08 2016
Cantel Medical To Acquire NAMSA's Sterility Assurance Products Division Feb 03 2016
Cantel Medical Subsidiary Mar Cor Purification Releases New 2016 Online Dialysis Water Catalog Jan 19 2016
CANTEL MEDICAL CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 14 2016
Medical Equipment Maker Cantel Wants A Global Reach Jan 13 2016
CANTEL MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jan 11 2016
Cantel Medical Corp. breached its 50 day moving average in a Bearish Manner : January 1, 2016 Jan 01 2016
Cantel Medical To Present At The 34th Annual J.P.Morgan Healthcare Conference Dec 28 2015
Cantel Medical To Present At The 34th Annual J.P.Morgan Healthcare Conference Dec 28 2015
Cantel Medical Corp. breached its 50 day moving average in a Bullish Manner : December 22, 2015 Dec 22 2015
Cantel Medical Corp. Earnings Analysis: Q1, 2016 By the Numbers Dec 17 2015
CANTEL MEDICAL CORP Financials Dec 16 2015
How Does Cantel Medical Compare with Its Peers? Dec 11 2015
Cantel Medical’s Revenue and Income Rise in Fiscal 1Q16 Dec 11 2015
Edited Transcript of CMN earnings conference call or presentation 10-Dec-15 4:00pm GMT Dec 10 2015
CANTEL MEDICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Dec 10 2015
Cantel Medical Reports Record Results For The First Quarter Ended October 31, 2015 Dec 10 2015
Cantel posts 1Q profit Dec 10 2015
Cantel posts 1Q profit Dec 10 2015
Cantel Medical Reports Record Results For The First Quarter Ended October 31, 2015 Dec 10 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK